411 related articles for article (PubMed ID: 22749192)
1. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
He J; Wang X; Zhao X; Liang Y; He H; Fu L
Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents.
Jiang N; Zhai X; Zhao Y; Liu Y; Qi B; Tao H; Gong P
Eur J Med Chem; 2012 Aug; 54():534-41. PubMed ID: 22727449
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
Luo H; Yang S; Cai Y; Peng Z; Liu T
Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of novel 2-(1-substituted-piperidin-4-ylamino)quinazolines as antitumor agents.
Wang YK; Jin J; Zhu LN; Zhang Y; Chen XG; Gao XQ; Xu BL
Yao Xue Xue Bao; 2012 Sep; 47(9):1164-78. PubMed ID: 23227546
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
Alafeefy AM; Ashour AE
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
[TBL] [Abstract][Full Text] [Related]
8. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
[TBL] [Abstract][Full Text] [Related]
9. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
[TBL] [Abstract][Full Text] [Related]
11. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
[TBL] [Abstract][Full Text] [Related]
12. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
[TBL] [Abstract][Full Text] [Related]
13. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues.
Al-Omary FA; Hassan GS; El-Messery SM; El-Subbagh HI
Eur J Med Chem; 2012 Jan; 47(1):65-72. PubMed ID: 22056277
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic potential of novel 6,7-dimethoxyquinazolines.
Yadav MR; Grande F; Chouhan BS; Naik PP; Giridhar R; Garofalo A; Neamati N
Eur J Med Chem; 2012 Feb; 48():231-43. PubMed ID: 22209417
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of substituted benzylamino- and heterocyclylmethylamino carbodithioate derivatives of 4-(3H)-quinazolinone and their cytotoxic activity.
Cao SL; Feng YP; Zheng XL; Jiang YY; Zhang M; Wang Y; Xu M
Arch Pharm (Weinheim); 2006 May; 339(5):250-4. PubMed ID: 16619282
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines.
Chandrika PM; Yakaiah T; Rao AR; Narsaiah B; Reddy NC; Sridhar V; Rao JV
Eur J Med Chem; 2008 Apr; 43(4):846-52. PubMed ID: 17689837
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.
Wang L; Li P; Li B; Wang Y; Li J; Song L
Molecules; 2017 Sep; 22(10):. PubMed ID: 28956845
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.
Li DD; Fang F; Li JR; Du QR; Sun J; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Sep; 22(18):5870-5. PubMed ID: 22901387
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]